Hospital Pharmacy Europe

JANUARY 28, 2023

RRx-001 reduced the duration of severe oral mucositis symptoms in patients with squamous cell carcinoma undergoing chemoradiation A first-in-class agent, RRx-001, has been found to reduce the duration of severe oral mucositis in patients undergoing chemoradiotherapy, in a Phase II placebo-controlled trial undertaken by US researchers. Oral mucositis (OM) represents a common and highly symptomatic complication of cancer therapy which negatively impacts upon patient’s quality of life.

Adverse Reactions 52

Adverse Reactions Compounding Hospitals 52

Pharma Manufacturing

JANUARY 28, 2023

It’s hard to believe that twenty years have passed since I penned the “From the Editor” message in the very first issue of Pharmaceutical Manufacturing magazine

40

40

The Guardian - Pharmaceutical Industry

JANUARY 28, 2023

Laura Poitras’s Oscar-nominated documentary chronicles the artist’s crusade against the philanthropic US billionaires fuelling of the opioid crisis A groundbreaking artist who turned the lens on her own life, who documented the fabulous, fragile, nocturnal world of Boston’s drag queens , who gravitated towards the fringes of society, who rocked the art world when she curated a show about Aids, who supported her photography with a stint as a sex worker: Nan Goldin is a fascinating subject for a d

Documentation 86

Documentation 86

Pharma Manufacturing

JANUARY 28, 2023

Adoption has been slower than predicted but the industry has made the advancements necessary to make pharmaceutical continuous manufacturing a reality

40

40

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Manufacturing

JANUARY 28, 2023

Collaboration in five key areas is critical to overcoming growth obstacles

49

49

Pharma Manufacturing

JANUARY 28, 2023

Pharma quality regulation has evolved beyond routine CGMP compliance toward a more holistic, proactive approach

40

40

Pharma Manufacturing

JANUARY 28, 2023

Twenty years later, integrated approaches are still key to streamlining capital project delivery

40

40

Pharma Manufacturing

JANUARY 28, 2023

Celebrating those who are au fait with the industry’s appetite for innovation

40

40

Pharma Manufacturing

JANUARY 28, 2023

Eli Lilly defused a reputational crisis. What more could it have done?

40

40

Pharma Manufacturing

JANUARY 28, 2023

Evaluating the risks and costs of unnecessary planned maintenance

40

40

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Manufacturing

JANUARY 28, 2023

From ‘just do it’ to lean transformation

40

40

Pharma Manufacturing

JANUARY 28, 2023

Join us for a journey back in time

40

40